Esmail El-Fakharany | Drug Delivery | Research Excellence Award

Published on by sciencefatherLeave a Comment on Esmail El-Fakharany | Drug Delivery | Research Excellence Award

Prof. Dr. Esmail El-Fakharany | Drug Delivery | Research Excellence Award

City of Scientific Research and Technological Applications | Egypt

Prof. Dr. Esmail El-Fakharany is a distinguished scientist affiliated with the Protein Research Department at the Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, where his work significantly advances biomedical and biotechnological research. He earned his Ph.D. in Microbiology with a minor specialization in biotechnology in 2012, following an M.Sc. in Microbiology with a focus on antiviral agents in 2009, both from the Faculty of Science, Al-Azhar University, Cairo. His academic foundation is further strengthened by a Diploma in Public Health Microbiology from the High Institute of Public Health, Alexandria University, and a B.Sc. in Microbiology with excellent distinction. Prof. Dr. El-Fakharany possesses extensive experience in immunology and immunoblotting, molecular biology, therapeutic protein and enzyme purification, antiviral and anticancer agent investigation, microbiological techniques, and tissue culture and cell line maintenance. His primary research interests center on antiviral proteins, recombinant and natural bioactive molecules, therapeutic protein engineering, immunological applications, and biotechnology-driven drug development. Through sustained scientific contributions, he has received professional recognition for excellence in microbiology and biotechnology research. Overall, his work continues to play a vital role in translating fundamental microbiological insights into innovative therapeutic strategies, contributing meaningfully to global health and applied life sciences.

View Google Scholar Profile

Featured Publications

Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study

Virology Journal, 2013, Vol. 10(1), Article 199

Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells

Protein & Peptide Letters, 2010, Vol. 17(8), pp. 1031–1039

Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and HeLa cell lines

Hepatitis Monthly, 2011, Vol. 11(9)

Potential lactoferrin activity against pathogenic viruses

Comptes Rendus Biologies, 2014, Vol. 337(10), pp. 581–595

Poly(vinyl alcohol)–hyaluronic acid membranes for wound dressing applications: synthesis and in vitro bio-evaluations

Journal of the Brazilian Chemical Society, 2015, Vol. 26(7), pp. 1466–1474

Radwa Mahmoud | Biotechnology | Excellence in Research Award

Published on by sciencefatherLeave a Comment on Radwa Mahmoud | Biotechnology | Excellence in Research Award

Ms. Radwa Mahmoud | Biotechnology | Excellence in Research Award

Biotechnology Department, Faculty of Science, Cairo University, Egypt

Ms. Radwa Mahmoud is an emerging biotechnology researcher with strong expertise in cancer therapeutics, molecular diagnostics, and nanoparticle biosynthesis. She is currently pursuing a Master’s degree in Biotechnology at Cairo University, where she previously completed her Bachelor’s degree with distinction, ranking among the top students. Her research interests span breast cancer treatment using scorpion-venom-derived peptides, CRISPR-based microbiome engineering, antimicrobial peptides, and the biomedical applications of nanomaterials. Radwa has extensive hands-on experience in wet-lab experimentation, diagnostic assay design, cytotoxicity analysis, molecular cloning, protein purification, and computational modeling. She has led multidisciplinary research projects focused on early breast cancer detection and innovative therapeutic models, earning competitive funding support from the Science and Technology Development Fund (STDF) and winning awards such as Best Poster at SOLE and a Silver Medal at the international iGEM competition. Her professional experience includes roles in pharmaceutical research and development, molecular biology laboratories, and academic teaching support. Radwa’s growing publication record and contributions to translational research highlight her commitment to advancing oncology, biotechnology innovation, and therapeutic discovery. She aims to continue developing impactful scientific solutions addressing global health challenges.

Profiles: Scopus | Orcid

Featured Publications

Amen, R.A. (2024). “Harnessing plant extracts for skin health and dermatological care: herbal wonders green solutions” in Herbal Wonders Green Solutions.

Amen, R.A. (2024). “Therapeutic potential and characteristics of Smp43 peptide (scorpion venom) and its interaction with cellular signaling pathways: a review” in Review.

Amen, R.A. (2024). “Exploring the potential of natural compounds in cancer treatment: a review” in Review.

Amen, R.A. (2024). “Coinfection of schistosomiasis and hepatitis C in Egypt: challenges and possible management strategies” in Review.

Amen, R.A. (2024). “Biosynthesis of silver, copper, and their bi-metallic nanocomposites by Staphylococcus aureus: their antimicrobial, anticancer activity, and cytotoxicity effect” in Journal Article.

Amen, R.A. (2023). “COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic” in Review.

Amen, R.A. (2022). “Pharmacological properties of 4′, 5, 7-trihydroxyflavone (apigenin) and its impact on cell signaling pathways” in Review.